| | | | |

Isolated Thoracic Perfusion for Mesothelioma Symptom Relief

ByAlex Strauss
isolated thoracic perfusion

A new study suggests that a treatment called isolated thoracic perfusion could help alleviate some of the worst symptoms of malignant pleural mesothelioma.

Isolated thoracic perfusion is a method for circulating medicine in just one area of the body. When doctors circulated chemotherapy drugs in the chests of people with pleural mesothelioma, their symptoms went away for several months. 

Now, the team says it is time to test the technique in a bigger pool of mesothelioma patients. 

The Theory Behind ITP

Pleural mesothelioma is a membrane cancer that occurs in the chest. Chemotherapy drugs like Alimta can be powerful weapons against pleural mesothelioma. But they can also damage healthy tissues. 

When healthy tissues are damaged by chemotherapy, mesothelioma patients can develop serious side effects. Some side effects of chemotherapy may even be fatal.

Isolated thoracic perfusion is a method for keeping chemotherapy drugs in just one area. The theory is that if these drugs only circulate where they are needed, they will do less damage. Less damage to healthy tissue means fewer mesothelioma treatment side effects. 

Testing Isolated Thoracic Perfusion for Mesothelioma

To keep medicine in the chest, doctors have to create a closed circulation loop. With the patient asleep, they temporarily block off some arteries with tiny balloons. They may also put tight cuffs around the arms.

Medicine flows through the circulatory system in the chest for a few minutes. Then the medicines are filtered out, the balloons are removed, and regular circulation resumes. 

Results of the New ITP Study

The latest test of isolated thoracic perfusion focused on mesothelioma patients who failed with regular chemotherapy. These 52 patients received treatment between 2000 and 2017. 

Only 8 percent of the patients had significant side effects from ITP. These had to do with white blood cell counts and neurological issues. They were not considered severe. 

A quarter of the mesothelioma tumors responded to isolated thoracic perfusion. It took a median of 7 months for patients’ tumors to start growing again after treatment. Some patients had additional treatments afterward. The median overall survival after ITP was 16 months. 

People with epithelioid mesothelioma responded better than those with non-epithelioid subtypes. The same was true for patients whose cancer was at Stage I or II. 

The treatment is not a cure for mesothelioma. But researchers conclude that isolated thoracic perfusion is “safe, tolerable and useful.” They are calling for more studies of ITP to find out if it should be a routine part of palliative care for mesothelioma. 

“Its inclusion in the multidisciplinary palliative treatment of progressive MPM patients should be investigated in a larger multicentre controlled study,” they write. 

A similar study in 2017 produced similar results. Those patients experienced progression-free mesothelioma survival of 9 months with no serious toxicity. 

Source:

Guadagni, S, et al, “Multidisciplinary palliative treatment including isolated thoracic perfusion for progressive malignant pleural mesothelioma: a retrospective observational study”, May-June 2019, Journal of the Balkan Union of Oncology, https://www.ncbi.nlm.nih.gov/pubmed/31424688

Aigner, KR, et al, “Isolated thoracic perfusion with chemofiltration for progressive malignant pleural mesothelioma”, June 2017, Oncotargets and Therapy, https://www.researchgate.net/publication/317679391_Isolated_thoracic_perfusion_with_chemofiltration_for_progressive_malignant_pleural_mesothelioma

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    ByAlex Strauss

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…